Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose 4-way crossover study of inhaled indacaterol maleate formulations in persistent asthma
2009-012600-48Phase 2Completed
- Sponsor
- Novartis
- Start
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of indacaterol in asthma (4 arms), sponsored by Novartis. Primary endpoint: Mean change in FEV1 from baseline to post-dose trough. Started Aug 2009; status: completed.
02
Drugs
indacaterol
03
Conditions
asthma
Beyond the preview
Go deeper on 2009-012600-48.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012600-48.